| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2324 |
| Trial ID | NCT04289220 |
| Disease | B-Cell Acute Lymphoblastic Leukemia | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 3rd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia |
| Year | 2020 |
| Country | China |
| Company sponsor | Yan'an Affiliated Hospital of Kunming Medical University |
| Other ID(s) | 2019-1-N-25318000002027 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||